Genesis 131,

on a change in control (as defined in our 2018 LTIP), the unvested service tranche of the outstanding LTIP cash awards granted in April 2025, April 2024 and April 2023 will become fully vested and the unvested performance tranche of such cash awards will vest at 200% of the performance metric. Based on a hypothetical change in control on December 31, 2025, the change of control benefits for Messrs. Grant E. Sims, Ryan S. Sims, Gaspard, and Alexander, and Ms. Jesulaitis would have been as follows: Grant E. Sims Ryan S. Sims Kristen O. Jesulaitis Garland G. Gaspard Richard R. Alexander Cash payment for vested awards under 2018 LTIP granted in 2025 $ 7,200,000 $ 3,600,000 $ 3,150,000 $ 1,350,000 $ 1,500,000 Cash payment for vested awards under 2018 LTIP granted in 2024 7,200,000 3,440,000 3,0

ereas no impairment expense was reported in 2025 (see “Results of Operations” below for additional details). These impacts were partially offset by: (i) an increase in general and administrative expenses of $28.0 million primarily related to an increase in third-party transaction costs incurred associated with the sale of the Alkali Business on February 28, 2025; (see “Results of Operations” below for additional details); (ii) an increase in depreciation and amortization expense of $25.4 million (see “Results of Operations” below for additional details); and (iii) a decrease in equity in earnings of equity investees of $10.7 million. We reported Net Loss from Discontinued Operations, net of tax of $423.7 million in 2025 and Net Income from Discontinued Operations, net of tax of $17.8 milli